Related Experiment Video
Updated: Jan 27, 2026

Basic Research in Plasma Medicine - A Throughput Approach from Liquids to Cells
Published on: November 17, 2017
Inactivation and Removal of Chikungunya Virus and Mayaro Virus from Plasma-derived Medicinal Products
Constanze Yue1, Sebastian Teitz2, Tomoyuki Miyabashi3
1Department of Virology, Paul-Ehrlich-Institut, 63225 Langen, Germany. Constanze.Yue@pei.de.
Background:
Chikungunya virus (CHIKV) and Mayaro virus (MAYV) are closely related members of the Semliki Forest complex within the genus alphavirus and are transmitted by arthropods, causing acute febrile illness in humans. CHIKV has spread to almost all continents, whereas autochthonous MAYV infections have been reported in South America and in the Caribbean. Nevertheless, there was concern about potential spread of MAYV to other regions similar to CHIKV in the past. The risk for transmission of emerging viruses by blood transfusion and the safety of plasma-derived medicinal products (PDMPs) are constant concerns. The manufacturing processes of PDMPs include procedures to inactivate/remove viruses.
Methods:
In this study, we investigated the reduction of MAYV and CHIKV by heat inactivation in various matrices, solvent/detergent treatment and nanofiltration.
Results:
Unexpectedly, MAYV was significantly more resistant to heat and solvent/detergent treatment compared to CHIKV. However, being similar in size, both MAYV and CHIKV were removed below the detection limit by 35 nm virus filters.
Conclusions:
The inactivation profiles of different alphavirus members vary considerably, even within the Semliki Forest Complex. However, robust dedicated viral inactivation/removal procedures commonly used in the plasma product industry are effective in inactivating or removing MAYV and CHIKV.
Insights
Mayaro virus (MAYV) and Chikungunya virus (CHIKV) show different resistance to inactivation methods. However, standard plasma product manufacturing effectively removes both alphaviruses, ensuring product safety.
Area of Science:
- Virology
- Public Health
- Biotechnology
Background:
- Chikungunya virus (CHIKV) and Mayaro virus (MAYV) are alphaviruses transmitted by arthropods, causing febrile illness.
- CHIKV has a global presence, while MAYV is found in South America and the Caribbean, with concerns about its potential spread.
- The transmission of emerging viruses via blood transfusion and the safety of plasma-derived medicinal products (PDMPs) are significant public health concerns.
Purpose of the Study:
- To investigate the efficacy of viral inactivation and removal procedures on Mayaro virus (MAYV) and Chikungunya virus (CHIKV).
- To assess the safety of plasma-derived medicinal products (PDMPs) concerning MAYV and CHIKV contamination.
Main Methods:
- Evaluation of heat inactivation in various matrices.
- Assessment of solvent/detergent treatment efficacy.
- Testing the effectiveness of 35 nm nanofiltration for virus removal.
Main Results:
- Mayaro virus (MAYV) demonstrated higher resistance to heat and solvent/detergent treatment compared to Chikungunya virus (CHIKV).
- Both MAYV and CHIKV were effectively removed below detection limits by 35 nm virus filters.
- Viral inactivation profiles within the Semliki Forest complex alphaviruses can vary significantly.
Conclusions:
- Despite differing inactivation sensitivities, robust viral inactivation and removal processes are crucial for PDMP safety.
- Standard industry procedures effectively inactivate or remove both MAYV and CHIKV.
- The findings support the continued safety of plasma-derived medicinal products against alphavirus contamination.
Related Concept Videos
What are Viruses?
X-Inactivation
Introduction to Virus
Viruses of Archaea
Viruses with RNA Genomes
Intracellular Movement of Viruses and Bacteria

